Choice of Growth Standard and Interpretation of Large for Gestational Age Outcomes: Evidence From the CDC4G Trial
Paediatric and Perinatal Epidemiology · 2026
DOI: 10.1111/ppe.70180 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Paediatric and Perinatal Epidemiology, 2026. Verfasst von Sara Grass und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Birth Weight, Diabetes, Gestational, Infant, Large for Gestational Age. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Research Council, ALF Funding Region Örebro County, The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement.
Abstract (Originalsprache)
Background
The lack of a standardised definition of large for gestational age (LGA) complicates clinical assessments and the interpretation of research.
Objective
The objective of this study is to assess how different definitions of LGA affect the interpretation of outcomes in a stepped wedge cluster randomised controlled trial (SW‐CRT).
Methods
Secondary analysis of the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G, ISRCTN41918550) study population ( n = 47,080 pregnancies), including eight delivery units in Sweden during 2018. The outcome measures were the prevalence of LGA and severe LGA before and after switching from the previous Swedish diagnostic criteria for gestational diabetes (SWE‐GDM) to the World Health Organisation (WHO‐2013) criteria. LGA and severe LGA were defined as birthweight > 90th and > 97th percentile, respectively, using the following reference growth charts: The new Swedish reference ranges for fetal weight (SWE‐REF), the Gestation Related Optimal Weight (GROW) and the International Fetal and Newborn Growth Consortium for the 21st Century (Intergrowth‐21st). Analyses were performed on a modified intention‐to‐treat (mITT) population and on the subgroup discordant for GDM diagnosis between new and former criteria, i.e., glucose levels between the WHO‐2013 and SWE‐GDM diagnostic thresholds.
Results
In the mITT population, the prevalence of LGA decreased from 19.4% to 13.1% after the switch to the WHO‐2013 GDM criteria, as defined by SWE‐REF (adjusted relative risk [RR], 0.92; 95% confidence interval [CI] 0.86, 0.98). There was no change in severe LGA using any of the reference charts. In the subgroup, LGA defined by SWE‐REF (RR 0.68, 95% CI 0.50, 0.91) and GROW (RR 0.78, 95% CI 0.63, 0.95) was reduced, but not when defined by Intergrowth‐21st (RR 0.88, 95% CI 0.74, 1.06). Severe LGA was reduced only when defined by Intergrowth‐21st (RR 0.73, 95% CI 0.62, 0.85).
Conclusions
The choice of LGA definition affected the interpretation of the results in the CDC4G trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
- Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
- Department of Obstetrics and Gynecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine, Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Sara Grass, Maryam de Brun, David Simmons, Karin Hildén, Helena Backman, Fredrik Ahlsson
Förderung
- The Swedish Research Council
- ALF Funding Region Örebro County
- The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement
- Nyckelfonden, Region Örebro County
- Region Örebro County Research committee
- Regional Research committee Uppsala-Örebro
- Stiftelsen Mary von Sydows, född Wijk, donation fund
- ALF Funding Region Uppsala
Zitieren
APA
Grass, S., de Brun, M., Magnuson, A., Persson, M., Wikström, A. K., Simmons, D., Patil, S., Sengpiel, V., Montgomery, S., Berntorp, K., Wennerholm, U. B., Strevens, H., Hildén, K., Storck-Lindholm, E., Backman, H., & Ahlsson, F. (2026). Choice of Growth Standard and Interpretation of Large for Gestational Age Outcomes: Evidence From the CDC4G Trial. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.70180
Vancouver
Grass S, de Brun M, Magnuson A, Persson M, Wikström AK, Simmons D, et al. Choice of Growth Standard and Interpretation of Large for Gestational Age Outcomes: Evidence From the CDC4G Trial. Paediatric and Perinatal Epidemiology. 2026. doi:10.1111/ppe.70180
BibTeX
@article{Grass2026,
author = {Grass, Sara and de Brun, Maryam and Magnuson, Anders and Persson, Martina and Wikström, Anna-Karin and Simmons, David and Patil, Snehal and Sengpiel, Verena and Montgomery, Scott and Berntorp, Kerstin and Wennerholm, Ulla-Britt and Strevens, Helena and Hildén, Karin and Storck-Lindholm, Elisabeth and Backman, Helena and Ahlsson, Fredrik},
title = {Choice of Growth Standard and Interpretation of Large for Gestational Age Outcomes: Evidence From the CDC4G Trial},
journal = {Paediatric and Perinatal Epidemiology},
year = {2026},
doi = {10.1111/ppe.70180}
}
EUVIMED